Interestingly, we found that 12 cases with PD-L1 expression had a worse prognosis, while PD-L1 expression was concentrated in WHO grade 2–3 meningiomas, and PD-L1 expression correlated positively with EZH2-positive cases. This evidence concerns the gene EZH2 and meningioma.